Global: ^ONCO(169.3

FileMan FileNo	FileMan Filename	Package
169.3	ICD-O-3 MORPHOLOGY	Oncology

FileMan FileNo

FileMan Filename

Package

169.3

ICD-O-3 MORPHOLOGY

Package	Total	Routines
Oncology	3	ONC2PS01 ONC2PS04 ONC2PS09

Package	Total	FileMan Files
Oncology	2	SITE-GROUP FOR ONCOLOGY(#164.2)[#164.23(.01)] ONCOLOGY PRIMARY(#165.5)[22.3]

Package	Total	FileMan Files
Oncology	3	ICDO TOPOGRAPHY(#164)[4, 4.1] ICDO-SITES(#164.08)[3] SEER CODE SET(#164.5)[43, 43.01, 43.02, 53, 53.01, 53.02]

Field #	Name	Loc	Type	Details
.001	NUMBER		NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99999)!(X<80000)!(X?.E1"."1N.N) X` LAST EDITED: `NOV 17, 2000` HELP-PROMPT: `Type a Number between 80000 and 99999, 0 Decimal Digits`
.01	NAME	0;1	FREE TEXT	**********************REQUIRED FIELD********************** INPUT TRANSFORM: `K:$L(X)>80!($L(X)<2)!'(X'?1P.E) X` LAST EDITED: `OCT 29, 2009` HELP-PROMPT: `Answer must be 2-80 characters in length.` DESCRIPTION: `Identifies the ICD-O (International Classification of Diseases for Oncology (Third Edition)) terms.` CROSS-REFERENCE: `169.3^B` `1)= S ^ONCO(169.3,"B",$E(X,1,30),DA)=""` `2)= K ^ONCO(169.3,"B",$E(X,1,30),DA)`
1	CODE	0;2	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>6!($L(X)<3) X` LAST EDITED: `NOV 20, 2000` HELP-PROMPT: `Answer must be 3-6 characters in length.` CROSS-REFERENCE: `169.3^D` `1)= S ^ONCO(169.3,"D",$E(X,1,30),DA)=""` `2)= K ^ONCO(169.3,"D",$E(X,1,30),DA)` `Indexes file by CODE.`
2	SYNONYM/EQUIVALENT TERM	1;0	Multiple #169.32	169.32 LAST EDITED: `JAN 31, 2001` DESCRIPTION: `This field contains the synonyms and equivalent terms for this morphology.`
3	ICDO-SITE	0;5	POINTER TO ICDO-SITES FILE (#164.08)	ICDO-SITES(#164.08) LAST EDITED: `NOV 20, 2000` DESCRIPTION: `POINTS TO THE ICDO SITE FILE.`
4	TOPOGRAPHY 1	0;6	POINTER TO ICDO TOPOGRAPHY FILE (#164)	ICDO TOPOGRAPHY(#164) LAST EDITED: `JAN 31, 2001` DESCRIPTION: `This field indicates a usual primary site (ICD-O TOPOGRPAHY) for this morphology.` CROSS-REFERENCE: `169.3^AC` `1)= S ^ONCO(169.3,"AC",$E(X,1,4),DA)=""` `2)= K ^ONCO(169.3,"AC",$E(X,1,4),DA)`
4.1	TOPOGRAPHY 2	0;3	POINTER TO ICDO TOPOGRAPHY FILE (#164)	ICDO TOPOGRAPHY(#164) LAST EDITED: `JAN 31, 2001` DESCRIPTION: `This field indicates a usual primary site (ICD-O TOPOGRPAHY) for this morphology.` CROSS-REFERENCE: `169.3^AC` `1)= S ^ONCO(169.3,"AC",$E(X,1,4),DA)=""` `2)= K ^ONCO(169.3,"AC",$E(X,1,4),DA)`
43	EXTENSION CODE SET-1ST ED	E;1	POINTER TO SEER CODE SET FILE (#164.5)	SEER CODE SET(#164.5) INPUT TRANSFORM: `S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>1" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `APR 06, 2001` DESCRIPTION: `This field identifies the set of codes used to characterize extension for this topography in the first edition of SEER Extent of Disease Codes and Coding Instructions.` SCREEN: `S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>1"` EXPLANATION: `A first edition extension code set may be selected.`
43.01	EXTENSION CODE SET-2ND ED	E;2	POINTER TO SEER CODE SET FILE (#164.5)	SEER CODE SET(#164.5) INPUT TRANSFORM: `S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `NOV 20, 2000` DESCRIPTION: `This field identifies the set of codes used to characterize extension for this topography in the second edition of SEER Extent of Disease Codes and Coding Instructions.` SCREEN: `S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>2"` EXPLANATION: `A first or second edition extension code set may be selected.`
43.02	EXTENSION CODE SET-3RD ED	E;3	POINTER TO SEER CODE SET FILE (#164.5)	SEER CODE SET(#164.5) INPUT TRANSFORM: `S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>3" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `NOV 20, 2000` DESCRIPTION: `This field identifies the set of codes used to characterize extension for this topography in the third edition of SEER Extent of Disease Codes and Coding Instructions.` SCREEN: `S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>3"` EXPLANATION: `A first, second or third edition extension code set may be selected.`
53	LYMPH NODE CODE SET-1ST ED	L;1	POINTER TO SEER CODE SET FILE (#164.5)	SEER CODE SET(#164.5) INPUT TRANSFORM: `S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>1" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `NOV 20, 2000` DESCRIPTION: `This field identifies the set of codes used to characterize lymph node involvement for this topography in the first edition of SEER Extent of Disease Codes and Coding Instructions.` SCREEN: `S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>1"` EXPLANATION: `A first edition lymph node code set may be selected.`
53.01	LYMPH NODE CODE SET-2ND ED	L;2	POINTER TO SEER CODE SET FILE (#164.5)	SEER CODE SET(#164.5) INPUT TRANSFORM: `S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `NOV 20, 2000` DESCRIPTION: `This field identifies the set of codes used to characterize lymph node involvement for this topography in the second edition of SEER Extent of Disease Codes and Coding Instructions.` SCREEN: `S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>2"` EXPLANATION: `A first or second edition lymph node code set may be selected.`
53.02	LYMPH NODE CODE SET-3RD ED	L;3	POINTER TO SEER CODE SET FILE (#164.5)	SEER CODE SET(#164.5) INPUT TRANSFORM: `S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>3" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `NOV 20, 2000` DESCRIPTION: `This field identifies the set of codes used to characterize lymph node involvement for this topography in the third edition of SEER Extent of Disease Codes and Coding Instructions.` SCREEN: `S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>3"` EXPLANATION: `A first, second or third edition lymph node code set may be selected.`
71	HISTOPATHOLOGIC TYPE	0;8	SET	'1' FOR Lymphoid; '2' FOR Embryonal; '3' FOR Epithelial; '4' FOR Reticuloendothelial; '5' FOR Sarcoma; '6' FOR Hematogenous; '7' FOR Melanoma; '8' FOR Nerve; '9' FOR Other; LAST EDITED: `NOV 20, 2000` DESCRIPTION: `The HISTOPATHOLOGIC TYPE is the category (type) of morphology according to cell type.`

NAME: CYST, EMBRYONIC	NAME: CYST, NEUROGLIAL-LINED	NAME: CYST, EPITHELIAL INCLUSION	NAME: CYST, COLLOID	NAME: SUSPICIOUS FOR MALIGNANT CELLS	NAME: HAMARTOMA	NAME: NEOPLASM, BENIGN	NAME: NEOPLASM, UNCERTAIN BENIGN OR MALIGNANT
NAME: NEOPLASM, IN SITU	NAME: NEOPLASM, MALIGNANT	NAME: TUMOR CELLS, BENIGN	NAME: TUMOR CELLS, UNCERTAIN BENIGN OR MALIGNANT	NAME: TUMOR CELLS IN SITU	NAME: TUMOR CELLS, MALIGNANT	NAME: IN SITU TUMOR, SMALL CELL TYPE	NAME: MALIGNANT TUMOR, SMALL CELL TYPE
NAME: IN SITU TUMOR, GIANT CELL TYPE	NAME: MALIGNANT TUMOR, GIANT CELL TYPE	NAME: IN SITU TUMOR, SPINDLE CELL TYPE	NAME: MALIGNANT TUMOR, SPINDLE CELL TYPE	NAME: CLEAR CELL TUMOR, NOS	NAME: CLEAR CELL TUMOR IN SITU	NAME: MALIGNANT TUMOR, CLEAR CELL TYPE	NAME: EPITHELIAL TUMOR, BENIGN
NAME: CARCINOMA IN SITU, NOS	NAME: CARCINOMA, NOS	NAME: EPITHELIOMA, BENIGN	NAME: EPITHELIOMA IN SITU	NAME: EPITHELIOMA, MALIGNANT	NAME: LARGE CELL CARCINOMA IN SITU	NAME: LARGE CELL CARCINOMA, NOS	NAME: LARGE CELL NEUROENDOCRINE CARCINOMA IN SITU
NAME: LARGE CELL NEUROENDOCRINE CARCINOMA	NAME: LARGE CELL CA WITH RHABDOID PHENOTYPE IN SITU	NAME: LARGE CELL CARCINOMA WITH RHABDOID PHENOTYPE	NAME: GLASSY CELL CARCINOMA IN SITU	NAME: GLASSY CELL CARCINOMA	NAME: CARCINOMA IN SITU, UNDIFFERENTIATED	NAME: CARCINOMA, UNDIFFERENTIATED, NOS	NAME: CARCINOMA IN SITU, ANAPLASTIC
NAME: CARCINOMA, ANAPLASTIC, NOS	NAME: PLEOMORPHIC CARCINOMA IN SITU	NAME: PLEOMORPHIC CARCINOMA	NAME: NUT CARCINOMA (C30.0, C31.9, C34._)	NAME: GIANT CELL AND SPINDLE CELL CARCINOMA IN SITU	NAME: GIANT CELL AND SPINDLE CELL CARCINOMA	NAME: GIANT CELL CARCINOMA IN SITU	NAME: GIANT CELL CARCINOMA
NAME: SPINDLE CELL CARCINOMA IN SITU	NAME: SPINDLE CELL CARCINOMA, NOS	NAME: PSEUDOSARCOMATOUS CARCINOMA IN SITU	NAME: PSEUDOSARCOMATOUS CARCINOMA	NAME: POLYGONAL CELL CARCINOMA IN SITU	NAME: POLYGONAL CELL CARCINOMA	NAME: CARCINOMA WITH OSTEOCLAST GIANT CELLS IN SITU	NAME: CARCINOMA WITH OSTEOCLAST-LIKE GIANT CELLS
NAME: TUMORLET, BENIGN	NAME: TUMORLET, NOS	NAME: SMALL CELL CARCINOMA IN SITU	NAME: SMALL CELL CARCINOMA, NOS	NAME: OAT CELL CARCINOMA IN SITU	NAME: OAT CELL CARCINOMA	NAME: SMALL CELL CARCINOMA IN SITU, FUSIFORM CELL	NAME: SMALL CELL CARCINOMA, FUSIFORM CELL
NAME: SMALL CELL CARCINOMA IN SITU, INTERMED CELL	NAME: SMALL CELL CARCINOMA, INTERMEDIATE CELL	NAME: COMBINED SMALL CELL CARCINOMA IN SITU	NAME: COMBINED SMALL CELL CARCINOMA	NAME: NON-SMALL CELL CARCINOMA IN SITU	NAME: NON-SMALL CELL CARCINOMA	NAME: PAPILLOMA, NOS	NAME: PAPILLARY CARCINOMA IN SITU
NAME: PAPILLARY CARCINOMA, NOS	NAME: VERRUCOUS PAPILLOMA	NAME: VERRUCOUS CARCINOMA IN SITU	NAME: WARTY CARCINOMA	NAME: SQUAMOUS CELL PAPILLOMA, NOS	NAME: PAPILLARY SQUAMOUS CELL CA, NON-INVASIVE	NAME: PAPILLARY SQUAMOUS CELL CARCINOMA	NAME: SQUAMOUS CELL PAPILLOMA, INVERTED
NAME: WARTY CARCINOMA IN SITU	NAME: CONDYLOMATOUS CARCINOMA (C60.0-C60.2, C60.9)	NAME: SQUAMOUS PAPILLOMATOSIS	NAME: SQUAMOUS CELL CARCINOMA IN SITU, NOS	NAME: SQUAMOUS CELL CARCINOMA, NOS	NAME: SQUAMOUS CELL CA IN SITU, KERATINIZING	NAME: SQUAMOUS CELL CARCINOMA, KERATINIZING, NOS	NAME: SQUAMOUS CA IN SITU/LRG CELL, NONKERATINIZING
NAME: SQUAMOUS CA, LARGE CELL, NONKERATINIZING, NOS	NAME: SQUAMOUS CA IN SITU/SML CELL, NONKERATINIZING	NAME: SQUAMOUS CELL CA, SMALL CELL, NONKERATINIZING	NAME: SQUAMOUS CELL CA IN SITU, SPINDLE CELL	NAME: SQUAMOUS CELL CARCINOMA, SPINDLE CELL	NAME: SQUAMOUS CELL CA IN SITU, ADENOID	NAME: SQUAMOUS CELL CARCINOMA, ADENOID	NAME: SQUAMOUS CELL CA IN SITU W QUES STROMAL INV
NAME: SQUAMOUS CELL CARCINOMA, MICROINVASIVE	NAME: SQUAMOUS INTRAEPITHELIAL NEOPLASIA, GRADE III	NAME: SQUAMOUS CELL CA IN SITU WITH HORN FORMATION	NAME: SQUAMOUS CELL CARCINOMA WITH HORN FORMATION	NAME: QUEYRAT ERYTHROPLASIA	NAME: BOWEN DISEASE	NAME: BOWEN DISEASE, MALIGNANT	NAME: LYMPHOEPITHELIAL CARCINOMA IN SITU
NAME: LYMPHOEPITHELIAL CARCINOMA	NAME: BASALOID SQUAMOUS CELL CARCINOMA IN SITU	NAME: BASALOID SQUAMOUS CELL CARCINOMA	NAME: SQUAMOUS CELL CA IN SITU, CLEAR CELL TYPE	NAME: SQUAMOUS CELL CARCINOMA, CLEAR CELL TYPE	NAME: SCC, HPV-POS (C01.9 C09.9 C10.2 C10.3 C10.8 C10.9 C31.0-C31.3 C31.9)	NAME: SCC, HPV-NEG (C01.9 C09.9 C10.2 C10.3 C10.8 C10.9 C31.0-C31.3 C31.9)	NAME: BASAL CELL TUMOR
NAME: BASAL CELL CARCINOMA, IN SITU	NAME: BASAL CELL CARCINOMA, NOS	NAME: MULTICENTRIC BASAL CELL CARCINOMA, IN SITU	NAME: MULTIFOCAL SUPERFICIAL BASAL CELL CARCINOMA	NAME: INFILTRATING BASAL CELL CARCINOMA IN SITU	NAME: INFILTRATING BASAL CELL CARCINOMA, NOS	NAME: BASAL CELL CARCINOMA IN SITU, FIBROEPITHELIAL	NAME: BASAL CELL CARCINOMA, FIBROEPITHELIAL
NAME: BASOSQUAMOUS CARCINOMA IN SITU	NAME: BASOSQUAMOUS CARCINOMA	NAME: METATYPICAL CARCINOMA IN SITU	NAME: METATYPICAL CARCINOMA	NAME: INTRAEPIDERMAL EPITHELIOMA OF JADASSOHN	NAME: BASAL CELL CARCINOMA IN SITU, NODULAR	NAME: BASAL CELL CARCINOMA, NODULAR	NAME: ADENOID BASAL CARCINOMA IN SITU
NAME: ADENOID BASAL CARCINOMA	NAME: TRICHOEPITHELIOMA	NAME: TRICHOBLASTIC CARCINOMA	NAME: TRICHOFOLLICULOMA	NAME: TRICHOLEMMOMA	NAME: TRICHILEMMOCARCINOMA IN SITU	NAME: TRICHILEMMOCARCINOMA	NAME: PILAR TUMOR
NAME: PILAR SHEATH ACANTHOMA	NAME: PILOMATRIXOMA, NOS	NAME: PILOMATRIX CARCINOMA IN SITU	NAME: PILOMATRIX CARCINOMA	NAME: TRANSITIONAL CELL PAPILLOMA, BENIGN	NAME: UROTHELIAL PAPILLOMA, NOS	NAME: TRANSITIONAL CELL CARCINOMA IN SITU	NAME: TRANSITIONAL CELL CARCINOMA, NOS
NAME: SCHNEIDERIAN PAPILLOMA, NOS	NAME: TRANSITIONAL CELL PAPILLOMA, INVERTED, NOS	NAME: SCHNEIDERIAN CARCINOMA IN SITU	NAME: SCHNEIDERIAN CARCINOMA	NAME: TRANSITIONAL CELL CA IN SITU, SPINDLE CELL	NAME: TRANSITIONAL CELL CARCINOMA, SPINDLE CELL	NAME: BASALOID CARCINOMA IN SITU	NAME: BASALOID CARCINOMA
NAME: CLOACOGENIC CARCINOMA IN SITU	NAME: CLOACOGENIC CARCINOMA	NAME: PAPILLARY TRANS CELL NEOPLASM OF LOW MALIG	NAME: PAPILLARY TRANSITIONAL CELL CA, NON-INVASIVE	NAME: PAPILLARY TRANSITIONAL CELL CARCINOMA	NAME: TRANSITIONAL CELL CA IN SITU, MICROPAPILLARY	NAME: TRANSITIONAL CELL CARCINOMA, MICROPAPILLARY	NAME: ADENOMA, NOS
NAME: ATYPICAL ADENOMA	NAME: ADENOCARCINOMA IN SITU, NOS	NAME: ADENOCARCINOMA, NOS	NAME: SCIRRHOUS ADENOCARCINOMA IN SITU	NAME: SCIRRHOUS ADENOCARCINOMA	NAME: LINITIS PLASTICA IN SITU	NAME: LINITIS PLASTICA	NAME: SUPERFICIAL SPREADING ADENOCARCINOMA IN SITU
NAME: SUPERFICIAL SPREADING ADENOCARCINOMA	NAME: INTESTINAL-TYPE ADENOMA, HIGH GRADE (C16._,C17._) [REPORTABLE 2022+	NAME: ADENOCARCINOMA, INTESTINAL TYPE	NAME: CARCINOMA IN SITU, DIFFUSE TYPE	NAME: CARCINOMA, DIFFUSE TYPE	NAME: MONOMORPHIC ADENOMA	NAME: BASAL CELL ADENOMA	NAME: BASAL CELL ADENOCARCINOMA IN SITU
NAME: BASAL CELL ADENOCARCINOMA	NAME: GLANDULAR INTRAEPITHELIAL NEOPLASIA, GR III	NAME: CANALICULAR ADENOMA	NAME: ISLET CELL ADENOMA	NAME: PACREATIC ENDOCRINE TUMOR, NOS (C25._)[PRE-2021 ONLY, FOR 2021+ 8150/3]	NAME: ISLET CELL CARCINOMA IN SITU	NAME: PANCREATIC ENDOCRINE TUMOR, NOS (C25.4)	NAME: INSULINOMA, NOS
NAME: INSULINOMA IN SITU	NAME: INSULINOMA, NOS (C25.4)	NAME: GLUCAGONOMA, NOS	NAME: GLUCAGONOMA IN SITU	NAME: GLUCAGONOMA	NAME: GASTRINOMA, NOS	NAME: GASTRINOMA IN SITU	NAME: GASTRINOMA
NAME: MIXED ISLET CELL AND EXOCRINE ADENOCA IN SITU	NAME: MIXED ISLET CELL AND EXOCRINE ADENOCARCINOMA	NAME: VIPOMA, NOS	NAME: VIPOMA IN SITU	NAME: VIPOMA	NAME: SOMATOSTATINOMA, NOS	NAME: SOMATOSTATINOMA IN SITU	NAME: SOMATOSTATINOMA
NAME: ENTEROGLUCAGONOMA, NOS	NAME: ENTEROGLUCAGONOMA IN SITU	NAME: ENTEROGLUCAGONOMA, MALIGNANT	NAME: ACTH-PRODUCING TUMOR [2018-2020 ONLY, FOR 2021+ USE CODE 8158/3]	NAME: ACTH-PRODUCING TUMOR	NAME: BILE DUCT ADENOMA	NAME: CHOLANGIOCARCINOMA IN SITU	NAME: CHOLANGIOCARCINOMA
NAME: BILE DUCT CYSTADENOMA	NAME: BILE DUCT CYSTADENOCARCINOMA IN SITU	NAME: BILE DUCT CYSTADENOCARCINOMA	NAME: KLATSKIN TUMOR IN SITU	NAME: KLATSKIN TUMOR	NAME: PAPILLARY NEOPLASM, PANCREATOBILIARY TYPE, WITH HIGH GRADE	NAME: PANCREATOBILIARY-TYPE CARCINOMA (C24.1)	NAME: LIVER CELL ADENOMA
NAME: HEPATOCELLULAR CA IN SITU	NAME: HEPATOCELLULAR CARCINOMA, NOS	NAME: HEPATOCELLULAR CA IN SITU, FIBROLAMELLAR	NAME: HEPATOCELLULAR CARCINOMA, FIBROLAMELLAR	NAME: HEPATOCELLULAR CA IN SITU, SCIRRHOUS	NAME: HEPATOCELLULAR CARCINOMA, SCIRRHOUS	NAME: HEPATOCELLULAR CA IN SITU, SPINDLE CELL VAR	NAME: HEPATOCELLULAR CA, SPINDLE CELL VARIANT
NAME: HEPATOCELLULAR CA IN SITU, CLEAR CELL TYPE	NAME: HEPATOCELLULAR CARCINOMA, CLEAR CELL TYPE	NAME: HEPATOCELLULAR CA IN SITU, PLEOMORPHIC TYPE	NAME: HEPATOCELLULAR CARCINOMA, PLEOMORPHIC TYPE	NAME: COMB HEPATOCELLULAR CA/CHOLANGIOCA IN SITU	NAME: COMB HEPATOCELLULAR CA AND CHOLANGIOCARCINOMA	NAME: TRABECULAR ADENOMA	NAME: TRABECULAR ADENOCARCINOMA IN SITU
NAME: TRABECULAR ADENOCARCINOMA	NAME: EMBRYONAL ADENOMA	NAME: ECCRINE DERMAL CYLINDROMA	NAME: ADENOID CYSTIC CARCINOMA IN SITU	NAME: ADENOID CYSTIC CARCINOMA	NAME: CRIBRIFORM CARCINOMA IN SITU	NAME: CRIBRIFORM CARCINOMA, NOS	NAME: MICROCYSTIC ADENOMA
NAME: LACTATING ADENOMA	NAME: ADENOMATOUS POLYP, NOS	NAME: ADENOCARCINOMA IN SITU IN ADENOMATOUS POLYP	NAME: ADENOCARCINOMA ADENOMATOUS IN POLYP	NAME: TUBULAR ADENOMA, NOS	NAME: TUBULAR ADENOCARCINOMA IN SITU	NAME: TUBULAR ADENOCARCINOMA	NAME: FLAT ADENOMA
NAME: SERRATED ADENOMA	NAME: SERRATED DYSPLASIA HIGH GRADE (C16._ , C17._)	NAME: SERRATED ADENOCARCINOMA (C18.0, C18.2, C18.9, C19.9, C20.9)	NAME: PARIETAL CELL CARCINOMA IN SITU	NAME: PARIETAL CELL CARCINOMA	NAME: ADENOCARCINOMA OF ANAL GLANDS IN SITU	NAME: ADENOCARCINOMA OF ANAL GLANDS	NAME: ADENOMATOUS POLYPOSIS COLI
NAME: ADENOCA IN SITU IN FAMILIAL POLYPOSIS COLI	NAME: ADENOCARCINOMA IN ADENOMATOUS POLYPOSIS COLI	NAME: MULTIPLE ADENOMATOUS POLYPS	NAME: ADENOCA IN SITU IN MULT ADENOMATOUS POLYPS	NAME: ADENOCARCINOMA IN MULTIPLE ADENOMATOUS POLYPS	NAME: DUCTAL CARCINOMA IN SITU, SOLID TYPE	NAME: SOLID CARCINOMA, NOS	NAME: CARCINOMA SIMPLEX IN SITU
NAME: CARCINOMA SIMPLEX	NAME: CARCINOID TUMOR OF UNCERTAIN MALIG POTENTIAL	NAME: CARCINOID TUMOR IN SITU	NAME: CARCINOID TUMOR, NOS	NAME: ENTEROCHROMAFFIN CELL CARCINOID IN SITU	NAME: ENTEROCHROMAFFIN CELL CARCINOID	NAME: ENTEROCHROMAFFIN-LIKE CELL CARCINOID, NOS	NAME: ENTEROCHROMAFFIN-LIKE CELL TUMOR IN SITU
NAME: ENTEROCHROMAFFIN-LIKE CELL TUMOR, MALIGNANT	NAME: GOBLET CELL CARCINOID IN SITU	NAME: GOBLET CELL ADENOCARCINOMA [2022+]	NAME: COMPOSITE CARCINOID IN SITU	NAME: COMPOSITE CARCINOID	NAME: TUBULAR CARCINOID	NAME: ADENOCARCINOID TUMOR IN SITU	NAME: ADENOCARCINOID TUMOR
NAME: NEUROENDOCRINE CARCINOMA IN SITU	NAME: NEUROENDOCRINE CARCINOMA, NOS	NAME: MERKEL CELL CARCINOMA, IN SITU	NAME: MERKEL CELL CARCINOMA	NAME: APUDOMA	NAME: ATYPICAL CARCINOID TUMOR IN SITU	NAME: ATYPICAL CARCINOID TUMOR	NAME: PULMONARY ADENOMATOSIS
NAME: ADENOCARCINOMA IN SITU, NON-MUCINOUS (C34._)	NAME: LEPIDIC ADENOCARCINOMA (C34._)	NAME: ALVEOLAR ADENOMA	NAME: ALVEOLAR ADENOCARCINOMA IN SITU	NAME: ALVEOLAR ADENOCARCINOMA	NAME: BRONCHIOLO-ALVEOLAR CA IN SITU, NON-MUCINOUS	NAME: BRONCHIOLO-ALVEOLAR CARCINOMA, NON-MUCINOUS	NAME: BRONCHIOLO-ALVEOLAR CA IN SITU, MUCINOUS
NAME: INVASIVE MUCINOUS ADENOCARCINOMA (C34._)	NAME: BRONCHIOLO-ALVEOLAR CA IN SITU, MIXED	NAME: MIXED INVASIVE MUCINOUS AND NON-MUCINOUS ADENOCARCINOMA (C34._)	NAME: ADENOCARCINOMA WITH MIXED SUBTYPES IN SITU	NAME: ADENOCARCINOMA WITH MIXED SUBTYPES	NAME: MINIMALLY INVASIVE ADENOCARCINOMA, NON-MUCINOUS (C34._)	NAME: MINIMALLY INVASIVE ADENOCARCINOMA, MUCINOUS (C34._)	NAME: PAPILLARY ADENOMA, NOS
NAME: PAPILLARY ADENOCARCINOMA IN SITU	NAME: PAPILLARY ADENOCARCINOMA, NOS	NAME: VILLOUS ADENOMA, NOS	NAME: ADENOCARCINOMA IN SITU IN VILLOUS ADENOMA	NAME: ADENOCARCINOMA IN VILLOUS ADENOMA	NAME: VILLOUS ADENOCARCINOMA IN SITU	NAME: VILLOUS ADENOCARCINOMA	NAME: TUBULOVILLOUS ADENOMA, NOS
NAME: ADENOCA IN SITU IN TUBULOVILLOUS ADENOMA	NAME: ADENOCARCINOMA IN TUBULOVILLOUS ADENOMA	NAME: PAPILLOMATOSIS, GLANDULAR	NAME: MICROPAPILLARY CARCINOMA, NOS (C18._, C19.9, C20.9, C34._)	NAME: CHROMOPHOBE ADENOMA	NAME: CHROMOPHOBE CARCINOMA IN SITU	NAME: CHROMOPHOBE CARCINOMA	NAME: PROLACTINOMA
NAME: PITUITARY ADENOMA, NOS	NAME: PITUITARY CARCINOMA IN SITU	NAME: PITUITARY CARCINOMA, NOS	NAME: PITUITARY BLASTOMA	NAME: ACIDOPHIL ADENOMA	NAME: ACIDOPHIL CARCINOMA IN SITU	NAME: ACIDOPHIL CARCINOMA	NAME: MIXED ACIDOPHIL-BASOPHIL ADENOMA
NAME: MIXED ACIDOPHIL-BASOPHIL CARCINOMA IN SITU	NAME: MIXED ACIDOPHIL-BASOPHIL CARCINOMA	NAME: OXYPHILIC ADENOMA	NAME: OXYPHILIC ADENOCARCINOMA IN SITU	NAME: OXYPHILIC ADENOCARCINOMA	NAME: BASOPHIL ADENOMA	NAME: BASOPHIL CARCINOMA IN SITU	NAME: BASOPHIL CARCINOMA
NAME: CLEAR CELL ADENOMA	NAME: CLEAR CELL ADENOCARCINOMA IN SITU	NAME: CLEAR CELL ADENOCARCINOMA, NOS	NAME: HYPERNEPHROID TUMOR	NAME: HEREDITARY LEIOMYOMATOSIS & RCC- ASSOCIATED RENAL CELL CARCINOMA (C64.9)	NAME: RENAL CELL CARCINOMA IN SITU	NAME: RENAL CELL CARCINOMA, NOS	NAME: CLEAR CELL ADENOFIBROMA
NAME: CLEAR CELL ADENOFIBROMA OF BORDERLINE MALIG	NAME: CLEAR CELL ADENOCARCINOFIBROMA IN SITU	NAME: CLEAR CELL ADENOCARCINOFIBROMA	NAME: LIPID RICH CARCINOMA IN SITU	NAME: LIPID RICH CARCINOMA	NAME: GLYCOGEN-RICH CARCINOMA IN SITU	NAME: GLYCOGEN-RICH CARCINOMA	NAME: CYST-ASSOCIATED RENAL CELL CARCINOMA IN SITU
NAME: CYST-ASSOCIATED RENAL CELL CARCINOMA	NAME: RENAL CELL CA IN SITU, CHROMOPHOBE TYPE	NAME: RENAL CELL CARCINOMA, CHROMOPHOBE TYPE	NAME: RENAL CELL CA IN SITU, SARCOMATOID	NAME: RENAL CELL CARCINOMA, SARCOMATOID	NAME: COLLECTING DUCT CARCINOMA IN SITU	NAME: COLLECTING DUCT CARCINOMA	NAME: GRANULAR CELL CARCINOMA IN SITU
NAME: GRANULAR CELL CARCINOMA	NAME: CHIEF CELL ADENOMA	NAME: WATER-CLEAR CELL ADENOMA	NAME: WATER-CLEAR CELL ADENOCARCINOMA IN SITU	NAME: WATER-CLEAR CELL ADENOCARCINOMA	NAME: MIXED CELL ADENOMA	NAME: MIXED CELL ADENOCARCINOMA IN SITU	NAME: MIXED CELL ADENOCARCINOMA
NAME: LIPOADENOMA	NAME: METANEPHRIC ADENOMA	NAME: FOLLICULAR ADENOMA	NAME: ATYPICAL FOLLICULAR ADENOMA	NAME: FOLLICULAR ADENOCARCINOMA IN SITU	NAME: FOLLICULAR ADENOCARCINOMA, NOS	NAME: FOLLICULAR ADENOCA IN SITU, WELL DIFF	NAME: FOLLICULAR ADENOCA, WELL DIFFERENTIATED
NAME: FOLLICULAR ADENOCA IN SITU, TRABECULAR	NAME: FOLLICULAR ADENOCARCINOMA, TRABECULAR	NAME: MICROFOLLICULAR ADENOMA, NOS	NAME: FETAL ADENOCARCINOMA IN SITU	NAME: FETAL ADENOCARCINOMA	NAME: MACROFOLLICULAR ADENOMA	NAME: FOLLICULAR TUMOR OF UNCERTAIN MALIGNANT POTENTIAL (C73.0)	NAME: FOLLICULAR CARCINOMA IN SITU
NAME: FOLLICULAR CARCINOMA, MINIMALLY INVASIVE	NAME: HYALINIZING TRABECULAR ADENOMA	NAME: HYALINIZING TRABECULAR ADENOMA	NAME: INSULAR CARCINOMA IN SITU	NAME: POORLY DIFFERENTIATED THYROID CARCINOMA (C73.9) {2021+]	NAME: FOLLICULAR THYROID CARCINOMA (FTC), ENCAPSULATED ANGOINVASIVE (C73.9)	NAME: PAPILLARY CA IN SITU, FOLLICULAR VARIANT	NAME: PAPILLARY CARCINOMA, FOLLICULAR VARIANT
NAME: PAPILLARY MICROCARCINOMA IN SITU	NAME: PAPILLARY MICROCARCINOMA	NAME: PAPILLARY CARCINOMA IN SITU, OXYPHILIC CELL	NAME: PAPILLARY CARCINOMA, OXYPHILIC CELL	NAME: NON-INV FOLLICULAR THYROID NEOPLASM W/ PAPILLARY-LIKE NUCLEAR FEATURE	NAME: PAPILLARY CARCINOMA, ENCAPSULATED	NAME: PAPILLARY CARCINOMA IN SITU, COLUMNAR CELL	NAME: PAPILLARY CARCINOMA, COLUMNAR CELL
NAME: MEDULLARY CARCINOMA W AMYLOID STROMA IN SITU	NAME: MEDULLARY CARCINOMA WITH AMYLOID STROMA	NAME: MIXED MEDULLARY-FOLLICULAR CARCINOMA IN SITU	NAME: MIXED MEDULLARY-FOLLICULAR CARCINOMA	NAME: MIXED MEDULLARY-PAPILLARY CARCINOMA IN SITU	NAME: MIXED MEDULLARY-PAPILLARY CARCINOMA	NAME: WELL DIFFERENTIATED TUMOR OF UNCERTAIN MALIGNANT POTENTIAL	NAME: NON-INVASIVE FOLLICULAR THYROID NEOPLASM W/PAPPILARY-LIKE FEATURES (C73.9)
NAME: NONENCAPSULATED SCLEROSING CARCINOMA IN SITU	NAME: NONENCAPSULATED SCLEROSING CARCINOMA	NAME: MULTIPLE ENDOCRINE ADENOMAS	NAME: JUXTAGLOMERULAR TUMOR	NAME: ADRENAL CORTICAL ADENOMA, NOS	NAME: ADRENAL CORTICAL CARCINOMA IN SITU	NAME: ADRENAL CORTICAL CARCINOMA	NAME: ADRENAL CORTICAL ADENOMA, COMPACT CELL
NAME: ADRENAL CORTICAL ADENOMA, PIGMENTED	NAME: ADRENAL CORTICAL ADENOMA, CLEAR CELL	NAME: ADRENAL CORTICAL ADENOMA, GLOMERULOSA CELL	NAME: ADRENAL CORTICAL ADENOMA, MIXED CELL	NAME: ENDOMETRIOID ADENOMA, NOS	NAME: ENDOMETRIOID ADENOMA, BORDERLINE MALIGNANCY	NAME: ENDOMETRIOID INTRAEPITHELIAL NEOPLASIA (C54._)[2018+;REPORTABLE 2021+]	NAME: ENDOMETRIOID ADENOCARCINOMA, NOS
NAME: ENDOMETRIOID ADENOFIBROMA, NOS	NAME: ENDOMETRIOID ADENOFIBROMA, BORDERLINE MALIG	NAME: ENDOMETRIOID ADENOFIBROMA IN SITU	NAME: ENDOMETRIOID ADENOFIBROMA, MALIGNANT	NAME: ENDOMETRIOID ADENOCA IN SITU, SECRETORY VAR	NAME: ENDOMETRIOID ADENOCA, SECRETORY VARIANT	NAME: ENDOMETRIOID ADENOCA IN SITU, CILIATED CELL	NAME: ENDOMETRIOID ADENOCA, CILIATED CELL VARIANT
NAME: ADENOCARCINOMA IN SITU, ENDOCERVICAL TYPE	NAME: ADENOCARCINOMA, ENDOCERVICAL TYPE	NAME: SKIN APPENDAGE ADENOMA	NAME: SKIN APPENDAGE CARCINOMA IN SITU	NAME: SKIN APPENDAGE CARCINOMA	NAME: FOLLICULAR FIBROMA	NAME: SYRINGOFIBROADENOMA	NAME: SWEAT GLAND ADENOMA
NAME: SWEAT GLAND TUMOR, NOS	NAME: SWEAT GLAND ADENOCARCINOMA IN SITU	NAME: SWEAT GLAND ADENOCARCINOMA	NAME: APOCRINE ADENOMA	NAME: APOCRINE ADENOCARCINOMA, IN SITU	NAME: APOCRINE ADENOCARCINOMA	NAME: NODULAR HIDRADENOMA	NAME: NODULAR HIDRADENOMA IN SITU
NAME: NODULAR HIDRADENOMA, MALIGNANT	NAME: ECCRINE SPIRADENOMA	NAME: ECCRINE SPIRADENOMA IN SITU	NAME: MALIGNANT ECCRINE SPIRADENOMA	NAME: HIDROCYSTOMA	NAME: PAPILLARY HIDRADENOMA	NAME: PAPILLARY SYRINGADENOMA	NAME: PAPILLARY SYRINGADENOCARCINOMA IN SITU
NAME: SYRINGOCYSTADENOCARCINOMA PAPILLIFERUM [2022+]	NAME: SYRINGOMA, NOS	NAME: SCLEROSING SWEAT DUCT CARCINOMA IN SITU	NAME: SCLEROSING SWEAT DUCT CARCINOMA	NAME: ECCRINE PAPILLARY ADENOMA	NAME: AGGRESSIVE DIGITAL PAPILLARY ADENOMA (PRE-2021 CASES)	NAME: ECCRINE PAPILLARY ADENOCARCINOMA IN SITU	NAME: AGGRESSIVE DIGITAL PAPILLARY ADENOMA (C44._)
NAME: ECCRINE POROMA	NAME: POROCARCINOMA IN SITU [2022+]	NAME: ECCRINE POROMA, MALIGNANT	NAME: SEBACEOUS ADENOMA	NAME: SEBACEOUS ADENOCARCINOMA IN SITU	NAME: SEBACEOUS ADENOCARCINOMA	NAME: ECCRINE ADENOCARCINOMA IN SITU	NAME: ECCRINE ADENOCARCINOMA
NAME: CERUMINOUS ADENOMA	NAME: CERUMINOUS ADENOCARCINOMA IN SITU	NAME: CERUMINOUS ADENOCARCINOMA	NAME: MUCOEPIDERMOID TUMOR	NAME: MUCOEPIDERMOID CARCINOMA IN SITU	NAME: MUCOEPIDERMOID CARCINOMA	NAME: CYSTADENOMA, NOS	NAME: SEROUS CYSTADENOMA OF UNC MALIGNANT POTENTIAL
NAME: CYSTADENOCARCINOMA IN SITU	NAME: CYSTADENOCARCINOMA, NOS	NAME: SEROUS CYSTADENOMA, NOS	NAME: SEROUS CYSTADENOCARCINOMA IN SITU	NAME: SEROUS CYSTADENOCARCINOMA, NOS	NAME: SEROUS CYSTADENOMA, BORDERLINE	NAME: CLEAR CELL CYSTADENOMA	NAME: CLEAR CELL CYSTIC/BORDERLINE MALIGNANCY
NAME: PAPILLARY CYSTADENOMA, NOS	NAME: PAPILLARY CYSTADENOCARCINOMA IN SITU	NAME: PAPILLARY CYSTADENOCARCINOMA, NOS	NAME: PAPILLARY CYSTADENOMA, BORDERLINE	NAME: SOLID PSEUDOPAPILLARY TUMOR (PRE-2021 CASES)	NAME: SOLID PSEUDOPAPILLARY CARCINOMA IN SITU	NAME: SOLID PSEUDOPAPILLARY NEOPLASM OF PANCREAS	NAME: INTRADUCTAL PAPILLARY-MUCINOUS ADENOMA
NAME: INTRADUCTAL PAPILLARY-MUCINOUS/MOD DYSPLASIA	NAME: INTRADUCTAL PAPILLARY-MUCINOUS CA, NON-INV	NAME: INTRADUCTAL PAPILLARY-MUCINOUS CA, INVASIVE	NAME: CYSTIC TUMOR OF ATRIO-VENTRICULAR NODE	NAME: INTRADUCTAL ONCOCYTIC PAPILLARY NEOPLASM, NOS	NAME: INTRADUCTAL ONCOCYTIC PAPILLARY NEOPLASM WITH ASSOCIATED INVASIVE CARCINOMA	NAME: PAPILLARY SEROUS CYSTADENOMA, NOS	NAME: PAPILLARY SEROUS CYSTADENOCARCINOMA IN SITU
NAME: PAPILLARY SEROUS CYSTADENOCARCINOMA	NAME: SEROUS SURFACE PAPILLOMA	NAME: SEROUS SURFACE PAPILLOMA OF UNC MALIGNANT POT	NAME: SEROUS SURFACE PAPILLARY CARCINOMA IN SITU	NAME: SEROUS SURFACE PAPILLARY CARCINOMA	NAME: SEROUS PAPILLARY CYSTIC TUMOR, BORDERLINE	NAME: SEROUS SURFACE PAPILLARY TUMOR/BORDERLINE MAL	NAME: MUCINOUS CYSTADENOMA, NOS
NAME: MUCINOUS CYSTIC TUMOR WITH MODERATE DYSPLASIA	NAME: MUCINOUS CYSTADENOCARCINOMA, NON-INVASIVE	NAME: MUCINOUS CYSTADENOCARCINOMA, NOS	NAME: PAPILLARY MUCINOUS CYSTADENOMA, NOS	NAME: PAPILLARY MUCINOUS CYSTADENOCARCINOMA IN SITU	NAME: PAPILLARY MUCINOUS CYSTADENOCARCINOMA (C56.9)	NAME: MUCINOUS CYSTIC TUMOR, BORDERLINE	NAME: PAPILLARY MUCINOUS CYSTADENOMA, BORDERLINE
NAME: SEROMUCINOUS CARCINOMA (C56.9)	NAME: MUCINOUS ADENOMA	NAME: LOW GRADE APPENDICEAL MUCINOUS NEOPLASM (C18.1)	NAME: HIGH GRADE APPENDICEAL MUCINOUS NEOPLASM (HAMN) (C181) [2022+]	NAME: MUCINOUS ADENOCARCINOMA	NAME: MUCIN-PRODUCING ADENOCARCINOMA IN SITU	NAME: MUCIN-PRODUCING ADENOCARCINOMA	NAME: MUCINOUS ADENOCA IN SITU, ENDOCERVICAL TYPE
NAME: MUCINOUS ADENOCARCINOMA, ENDOCERVICAL TYPE	NAME: ADENOCARCINOMA IN SITU, HPV-ASSOCIATED	NAME: ADENOCARCINOMA HPV-ASSOCIATED	NAME: ADENOCARCINOMA IN SITU HPV-INDEPENDENT	NAME: ADENOCARCINOMA HPV-INDEPENDENT NOS	NAME: SIGNET RING CELL CARCINOMA IN SITU	NAME: SIGNET RING CELL CARCINOMA	NAME: DUCTAL CARCINOMA, NONINFILTRATING, NOS
NAME: INFILTRATING DUCT CARCINOMA, NOS	NAME: COMEDOCARCINOMA, NONINFILTRATING	NAME: COMEDOCARCINOMA, NOS	NAME: JUVENILE CARCINOMA, IN SITU, OF BREAST	NAME: SECRETORY CARCINOMA OF BREAST	NAME: INTRADUCTAL PAPILLOMA	NAME: NONINFILTRATING INTRADUCTAL PAPILLARY ADENOCA	NAME: INTRADUCTAL PAPILLARY ADENOCA WITH INVASION
NAME: INTRACYSTIC PAPILLARY ADENOMA	NAME: NONINFILTRATING INTRACYSTIC CARCINOMA	NAME: INTRACYSTIC CARCINOMA, NOS	NAME: INTRADUCTAL PAPILLOMATOSIS, NOS	NAME: ADENOMA OF NIPPLE	NAME: INTRADUCTAL MICROPAPILLARY CARCINOMA	NAME: INVASIVE MICROPAPILLARY CARCINOMA (C50._)	NAME: CYSTIC HYPERSECRETORY CARCINOMA IN SITU
NAME: CYSTIC HYPERSECRETORY CARCINOMA	NAME: SOLID PAPILLARY CARCINOMA IN SITU (C50._)	NAME: TALL CELL CARCINOMA WITH REVERSED POLARITY [2022+]	NAME: MEDULLARY CARCINOMA IN SITU	NAME: MEDULLARY CARCINOMA, NOS	NAME: MEDULLARY CARCINOMA W LYMPHOID STROMA IN SITU	NAME: MEDULLARY CARCINOMA WITH LYMPHOID STROMA	NAME: ATYPICAL MEDULLARY CARCINOMA IN SITU
NAME: ATYPICAL MEDULLARY CARCINOMA	NAME: DUCT CARCINOMA IN SITU, DESMOPLASTIC TYPE	NAME: DUCT CARCINOMA, DESMOPLASTIC TYPE	NAME: PLEOMORPHIC LOBULAR CARCINOMA IN SITU (C50._)	NAME: LOBULAR CARCINOMA IN SITU, NOS	NAME: LOBULAR CARCINOMA, NOS	NAME: INFILTRATING DUCTULAR CARCINOMA IN SITU	NAME: INFILTRATING DUCTULAR CARCINOMA
NAME: INFILTRATING DUCT AND LOBULAR CA IN SITU	NAME: INFILTRATING DUCT AND LOBULAR CARCINOMA	NAME: INFILTRATING DUCT IN SITU W OTHER TYPES OF CA	NAME: INFILTRATING DUCT MIXED W OTHER TYPES OF CA	NAME: IN SITU LOBULAR MIXED WITH OTHER IN SITU CA	NAME: INFILTRATING LOBULAR MIXED W OTHER TYPES CA	NAME: POLYMORPHOUS LOW GRADE ADENOCARCINOMA IN SITU	NAME: POLYMORPHOUS LOW GRADE ADENOCARCINOMA
NAME: INFLAMMATORY CARCINOMA IN SITU	NAME: INFLAMMATORY CARCINOMA	NAME: PAGET DISEASE, MAMMARY, IN SITU	NAME: PAGET DISEASE, MAMMARY	NAME: PAGET DISEASE/INFLT DUCT CA OF BREAST IN SITU	NAME: PAGET DISEASE/INFILTRATING DUCT CA OF BREAST	NAME: PAGET DISEASE, EXTRAMAMMARY, IN SITU	NAME: PAGET DISEASE, EXTRAMAMMARY
NAME: PAGET DISEASE/INTRADUCT CA OF BREAST IN SITU	NAME: PAGET DISEASE AND INTRADUCTAL CA OF BREAST	NAME: ACINAR CELL ADENOMA	NAME: ACINAR CELL TUMOR	NAME: ACINAR CELL CARCINOMA IN SITU	NAME: ACINAR CELL CARCINOMA	NAME: ACINAR CELL CYSTADENOCARCINOMA IN SITU	NAME: ACINAR CELL CYSTADENOCARCINOMA
NAME: MIXED ACINAR DUCTAL CARCINOMA	NAME: MIXED SQUAMOUS CELL AND GLANDULAR PAPILLOMA	NAME: ADENOSQUAMOUS CARCINOMA IN SITU	NAME: ADENOSQUAMOUS CARCINOMA	NAME: ADENOLYMPHOMA	NAME: EPITHELIAL-MYOPITHELIAL CARCINOMA IN SITU	NAME: EPITHELIAL-MYOPITHELIAL CARCINOMA	NAME: LYMPHADENOMA
NAME: ADENOCARCINOMA W SQUAMOUS METAPLASIA IN SITU	NAME: ADENOCARCINOMA WITH SQUAMOUS METAPLASIA	NAME: ADENOCA W CARTILAG & OSSEOUS METAPLAS IN SITU	NAME: ADENOCA W CARTILAGINOUS & OSSEOUS METAPLASIA	NAME: ADENOCA W SPINDLE CELL METAPLASIA IN SITU	NAME: ADENOCARCINOMA WITH SPINDLE CELL METAPLASIA	NAME: ADENOCA W APOCRINE METAPLASIA IN SITU	NAME: ADENOCARCINOMA WITH APOCRINE METAPLASIA
NAME: ADENOCA W NEUROENDOCRINE DIFF IN SITU	NAME: ADENOCA WITH NEUROENDOCRINE DIFFERENTIATION	NAME: METAPLASTIC CARCINOMA IN SITU	NAME: METAPLASTIC CARCINOMA, NOS	NAME: HEPATOID ADENOCARCINOMA IN SITU	NAME: HEPATOID ADENOCARCINOMA	NAME: THYMOMA, BENIGN	NAME: THYMOMA, NOS
NAME: THYMOMA, IN SITU	NAME: THYMOMA, NOS (C37.9)	NAME: THYMOMA, TYPE A, NOS	NAME: THYMOMA, TYPE A, IN SITU	NAME: TYPE A THYMOMA INCLUDING ATYPICAL VARIANT (C37.9)	NAME: THYMOMA, TYPE AB, NOS	NAME: THYMOMA, TYPE AB, IN SITU	NAME: TYPE AB THYMOMA (C37.9)
NAME: THYMOMA, TYPE B1, NOS	NAME: THYMOMA, TYPE B1, IN SITU	NAME: TYPE B1 THYMOMA (C37.9)	NAME: THYMOMA, TYPE B2, NOS	NAME: THYMOMA, TYPE B2, IN SITU	NAME: TYPE B2 THYMOMA (C37.9)	NAME: THYMOMA, TYPE B3, NOS	NAME: THYMOMA, TYPE B3, IN SITU
NAME: TYPE B3 THYMOMA (C37.9)	NAME: THYMIC CARCINOMA IN SITU	NAME: THYMIC CARCINOMA, NOS	NAME: ECTOPIC HAMARTOMATOUS THYMOMA	NAME: SPINDLE EPITHELIAL TUM W THYMUS ELEM IN SITU	NAME: SPINDLE EPITHELIAL TUMOR W THYMUS-LIKE ELEM	NAME: CARCINOMA SHOWING THYMUS-LIKE ELEMENT IN SITU	NAME: INTRATHYROID THYMIC CARCINOMA (C73.9) [2021+]
NAME: SEX CORD-GONADAL STROMAL TUMOR	NAME: SEX CORD-GONADAL STROMAL TUMOR, INC DIFF	NAME: SEX CORD-GONADAL STROMAL TUMOR, MIXED FORMS	NAME: STROMAL TUMOR WITH MINOR SEX CORD ELEMENTS	NAME: MIXED GERM CELL SEX CORD-STROMAL TUMOR, UNCLASSIFIED (C48.2, C56.9, C57.9)	NAME: THECOMA, NOS	NAME: THECOMA IN SITU	NAME: THECOMA, MALIGNANT
NAME: THECOMA, LUTEINIZED	NAME: SCLEROSING STROMAL TUMOR	NAME: LUTEOMA, NOS	NAME: GRANULOSA CELL TUMOR, ADULT TYPE	NAME: GRANULOSA CELL TUMOR IN SITU	NAME: GRANULOSA CELL TUMOR, ADULT TYPE (C56.9)	NAME: GRANULOSA CELL-THECA CELL TUMOR	NAME: GRANULOSA CELL-THECA CELL TUMOR IN SITU
NAME: GRANULOSA CELL-THECA CELL TUMOR, MALIGNANT	NAME: GRANULOSA CELL TUMOR, JUVENILE	NAME: JUVENILE GRANULOSA CELL TUMOR IN SITU	NAME: JUVENILE GRANULOSA CELL TUMOR, MALIGNANT	NAME: SEX CORD TUMOR WITH ANNULAR TUBULES	NAME: ANDROBLASTOMA, BENIGN	NAME: ANDROBLASTOMA, NOS	NAME: ANDROBLASTOMA IN SITU
NAME: ANDROBLASTOMA, MALIGNANT	NAME: SERTOLI-LEYDIG CELL TUMOR, WELL DIFF	NAME: SERTOLI-LEYDIG CELL TUMOR, INTERMEDIATE DIFF	NAME: SERTOLI-LEYDIG CELL TUMOR IN SITU, POOR DIFF	NAME: SERTOLI-LEYDIG CELL TUMOR, POORLY DIFF	NAME: GYNANDROBLASTOMA	NAME: TUBULAR ANDROBLASTOMA IN SITU	NAME: TUBULAR ANDROBLASTOMA, MALIGNANT
NAME: SERTOLI-LEYDIG CELL TUMOR, RETIFORM	NAME: SERTOLI-LEYDIG CELL TUMOR, INT DIFF, HET ELEM	NAME: SERTOLI-LEYDIG CELL TUMOR IN SITU, HET ELEM	NAME: SERTOLI-LEYDIG CELL TUMOR, POOR DIFF, HET ELE	NAME: SERTOLI CELL TUMOR, NOS	NAME: SERTOLI CELL CARCINOMA IN SITU	NAME: SERTOLI CELL CARCINOMA	NAME: SERTOLI CELL TUMOR WITH LIPID STORAGE
NAME: LARGE CELL CALCIFYING SERTOLI CELL TUMOR	NAME: INTRATUBULAR LARGE CELL HYALINIZING SERTOLI CELL NEOPLASIA	NAME: LEYDIG CELL TUMOR, BENIGN	NAME: LEYDIG CELL TUMOR, NOS	NAME: LEYDIG CELL TUMOR IN SITU	NAME: LEYDIG CELL TUMOR, MALIGNANT	NAME: HILUS CELL TUMOR	NAME: LIPID CELL TUMOR OF OVARY
NAME: STEROID CELL TUMOR IN SITU	NAME: STEROID CELL TUMOR, MALIGNANT	NAME: ADRENAL REST TUMOR	NAME: PARAGANGLIOMA, BENIGN	NAME: PARAGANGLIOMA, NOS	NAME: PARAGANGLIOMA IN SITU	NAME: PARAGANGLIOMA, MALIGNANT	NAME: SYMPATHETIC PARAGANGLIOMA
NAME: SYMPATHETIC PARAGANGLIOMA	NAME: PARASYMPATHETIC PARAGANGLIOMA	NAME: PARASYMPATHETIC PARAGANGLIOMA	NAME: GANGLIOCYTIC PARAGANGLIOMA	NAME: GLOMUS JUGULARE TUMOR, NOS	NAME: MIDDLE EAR PARAGANGLIOMA (C30.1, C75.5)	NAME: AORTIC BODY TUMOR (PRE-2021 CASES)	NAME: AORTIC BODY TUMOR IN SITU
NAME: AORTIC BODY TUMOR (C75.5)	NAME: CAROTID BODY TUMOR	NAME: CAROTID BODY TUMOR IN SITU	NAME: CAROTID BODY PARAGANGLIOMA (C75.4)	NAME: EXTRA-ADRENAL PARAGANGLIOMA, NOS (PRE-2021 CASES)	NAME: EXTRA-ADRENAL PARAGANGLIOMA IN SITU	NAME: EXTRA-ADRENAL PARAGANGLIOMA, NOS	NAME: PHEOCHROMOCYTOMA, NOS (PRE-2021 CASES)
NAME: PHEOCHROMOCYTOMA IN SITU	NAME: PHEOCHROMOCYTOMA, NOS (C74.1)	NAME: GLOMANGIOSARCOMA IN SITU	NAME: GLOMANGIOSARCOMA	NAME: GLOMUS TUMOR, NOS	NAME: GLOMUS TUMOR IN SITU	NAME: GLOMUS TUMOR, MALIGNANT	NAME: GLOMANGIOMA
NAME: GLOMANGIOMYOMA	NAME: PECOMA, MALIGNANT	NAME: PIGMENTED NEVUS, NOS	NAME: MELANOMA IN SITU	NAME: MALIGNANT MELANOMA, NOS	NAME: NODULAR MELANOMA, IN SITU	NAME: NODULAR MELANOMA	NAME: BALLOON CELL NEVUS
NAME: BALLOON CELL MELANOMA, IN SITU	NAME: BALLOON CELL MELANOMA	NAME: HALO NEVUS	NAME: MELANOMA IN SITU, REGRESSING	NAME: MALIGNANT MELANOMA, REGRESSING	NAME: NEURONEVUS	NAME: MAGNOCELLULAR NEVUS	NAME: MELANOCYTOMA OF UNCERTAIN MALIGNANT POTENTIAL
NAME: MAGNOCELLULAR MELANOMA IN SITU	NAME: MAGNOCELLULAR MELANOMA	NAME: DYSPLASTIC NEVUS	NAME: DIFFUSE MELANOCYTOSIS	NAME: MENINGEAL MELANOCYTOMA	NAME: MENINGEAL MELANOMATOSIS IN SITU	NAME: MENINGEAL MELANOMATOSIS	NAME: NONPIGMENTED NEVUS
NAME: AMELANOTIC MELANOMA, IN SITU	NAME: AMELANOTIC MELANOMA	NAME: JUNCTIONAL NEVUS, NOS	NAME: MALIGNANT MELANOMA IN SITU/JUNCTIONAL NEVUS	NAME: MALIGNANT MELANOMA IN JUNCTIONAL NEVUS	NAME: PRECANCEROUS MELANOSIS, NOS	NAME: MALIGNANT MELANOMA IN PRECANCEROUS MELANOSIS	NAME: LENTIGINOUS MELANOCYTIC NEVUS
NAME: LENTIGO MALIGNA	NAME: LENTIGO MALIGNA MELANOMA	NAME: SUPERFICIAL SPREADING MELANOMA, IN SITU	NAME: LOW CUMULATIVE SUN DAMAGED MELANOMA (C44._) [2021+]	NAME: ACRAL LENTIGINOUS MELANOMA, IN SITU	NAME: ACRAL LENTIGINOUS MELANOMA, MALIGNANT	NAME: DESMOPLASTIC MELANOMA IN SITU	NAME: DESMOPLASTIC MELANOMA, MALIGNANT
NAME: MUCOSAL LENTIGINOUS MELANOMA IN SITU	NAME: MUCOSAL LENTIGINOUS MELANOMA	NAME: INTRADERMAL NEVUS	NAME: COMPOUND NEVUS	NAME: SMALL CONGENITAL NEVUS	NAME: GIANT PIGMENTED NEVUS, NOS	NAME: MELANOMA IN SITU IN GIANT PIGMENTED NEVUS	NAME: MALIGNANT MELANOMA IN GIANT PIGMENTED NEVUS
NAME: PROLIFERATIVE DERMAL LESION CONGENITAL NEVUS	NAME: EPITHELIOID AND SPINDLE CELL NEVUS	NAME: MIXED EPITHELIOID/SPINDLE CELL MELA IN SITU	NAME: MIXED EPITHELIOID AND SPINDLE CELL MELANOMA	NAME: EPITHELIOID CELL NEVUS	NAME: EPITHELIOID CELL MELANOMA IN SITU	NAME: EPITHELIOID CELL MELANOMA	NAME: SPINDLE CELL NEVUS, NOS
NAME: SPINDLE CELL MELANOMA IN SITU	NAME: SPINDLE CELL MELANOMA, NOS	NAME: SPINDLE CELL MELANOMA IN SITU, TYPE A	NAME: SPINDLE CELL MELANOMA, TYPE A	NAME: SPINDLE CELL MELANOMA IN SITU, TYPE B	NAME: SPINDLE CELL MELANOMA, TYPE B	NAME: BLUE NEVUS, NOS	NAME: BLUE NEVUS IN SITU
NAME: BLUE NEVUS, MALIGNANT	NAME: CELLULAR BLUE NEVUS	NAME: SOFT TISSUE TUMOR, BENIGN	NAME: SARCOMA IN SITU	NAME: SARCOMA, NOS	NAME: SPINDLE CELL SARCOMA IN SITU	NAME: SPINDLE CELL SARCOMA	NAME: GIANT CELL SARCOMA IN SITU
NAME: GIANT CELL SARCOMA	NAME: SMALL CELL SARCOMA IN SITU	NAME: SMALL CELL SARCOMA	NAME: EPITHELIOID SARCOMA IN SITU	NAME: EPITHELIOID SARCOMA	NAME: UNDIFFERENTIATED SARCOMA INS SITU	NAME: UNDIFFERENTIATED SARCOMA	NAME: DESMOPLASTIC SMALL ROUND CELL TUMOR IN SITU
NAME: DESMOPLASTIC SMALL ROUND CELL TUMOR	NAME: FIBROMA, NOS	NAME: CELLULAR FIBROMA	NAME: FIBROSARCOMA IN SITU	NAME: FIBROSARCOMA, NOS	NAME: FIBROMYXOMA	NAME: MYXOINFLAMMATORY FIBROBLASTIC SARCOMA (mifs) (C49._)	NAME: FIBROMYXOSARCOMA IN SITU
NAME: FIBROMYXOSARCOMA	NAME: PERIOSTEAL FIBROMA	NAME: PERIOSTEAL FIBROSARCOMA IN SITU	NAME: PERIOSTEAL FIBROSARCOMA	NAME: FASCIAL FIBROMA	NAME: FASCIAL FIBROSARCOMA IN SITU	NAME: FASCIAL FIBROSARCOMA	NAME: INFANTILE FIBROSARCOMA IN SITU
NAME: INFANTILE FIBROSARCOMA	NAME: SOLITARY FIBROUS TUMOR	NAME: SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA GRADE 2 (CNS) (C71._)	NAME: SOLITARY FIBROUS TUMOR IN SITU	NAME: SOLITARY FIBROUS TUMOR, MALIGNANT	NAME: CALCIFYING APONEUROTIC FIBROMA	NAME: CALCIYING FIBROUS TUMOR	NAME: FIBROUS DYSPLASIA
NAME: ELASTOFIBROMA	NAME: AGGRESSIVE FIBROMATOSIS	NAME: AGGRESSIVE FIBROMATOSIS IN SITU	NAME: AGGRESSIVE FIBROMATOSIS, MALIGNANT	NAME: ABDOMINAL FIBROMATOSIS	NAME: DESMOPLASTIC FIBROMA	NAME: MYOFIBROMA	NAME: MYOFIBROMATOSIS
NAME: MYOFIBROBLASTOMA	NAME: MYOFIBROBLASTIC TUMOR, NOS	NAME: MYOFIBROBLASTIC SARCOMA	NAME: ANGIOMYOFIBROBLASTOMA	NAME: MYOFIBROBLASTIC TUMOR, PERIBRONCHIAL	NAME: NODULAR FASCIITIS	NAME: BENIGN FIBROUS HISTIOCYTOMA	NAME: ATYPICAL FIBROUS HISTIOCYTOMA
NAME: FIBROUS HISTIOCYTOMA IN SITU	NAME: MALIGNANT FIBROUS HISTIOCYTOMA	NAME: HISTIOCYTOMA, NOS	NAME: DERMATOFIBROMA, NOS	NAME: DERMATOFIBROSARCOMA PROTUBERANS, NOS (C44._) [2021+, NOT REPORTABLE FOR PRE-2021	NAME: DERMATOFIBROSARCOMA IN SITU	NAME: DERMATOFIBROSARCOMA PROTUBERANS, FIBROSARCOMATOUS	NAME: PIGMENTED DERMATOFIBROSARCOMA PROTUBERANS (C44._)
NAME: PIGMENTED DERMATOFIBROSARCOMA PROTUBE IN SITU	NAME: PIGMENTED DERMATOFIBROSARCOMA PROTUBERANS (PRE-2021 CASES)	NAME: GIANT CELL FIBROBLASTOMA	NAME: PLEXIFORM FIBROHISTIOCYTIC TUMOR	NAME: ANGIOMATOID FIBROUS HISTIOCYTOMA	NAME: MYXOMA, NOS	NAME: MYXOSARCOMA IN SITU	NAME: MYXOSARCOMA
NAME: ANGIOMYXOMA	NAME: ANGIOMYXOMA	NAME: OSSIFYING FIBROMYXOID TUMOR	NAME: PULMONARY MYXOID SARCOMA WITH EWSR1-CREB1 TRANSLOCATION (C34._)	NAME: LIPOMA, NOS	NAME: ATYPICAL LIPOMA	NAME: LIPOSARCOMA IN SITU	NAME: LIPOSARCOMA, NOS
NAME: FIBROLIPOMA	NAME: LIPOSARCOMA IN SITU, WELL DIFFERENTIATED	NAME: LIPOSARCOMA, WELL DIFFERENTIATED	NAME: FIBROMYXOLIPOMA	NAME: MYXOID LIPOSARCOMA IN SITU	NAME: MYXOID LIPOSARCOMA	NAME: ROUND CELL LIPOSARCOMA IN SITU	NAME: ROUND CELL LIPOSARCOMA
NAME: PLEOMORPHIC LIPOMA	NAME: LIPOSARCOMA IN SITU, PLEOMORPHIC	NAME: LIPOSARCOMA, PLEOMORPHIC	NAME: MIXED LIPOSARCOMA IN SITU	NAME: MIXED LIPOSARCOMA	NAME: INTRAMUSCULAR LIPOMA	NAME: SPINDLE CELL LIPOMA	NAME: FIBROBLASTIC LIPOSARCOMA IN SITU
NAME: FIBROBLASTIC LIPOSARCOMA	NAME: DEDIFFERENTIATED LIPOSARCOMA IN SITU	NAME: DEDIFFERENTIATED LIPOSARCOMA	NAME: MYXOID PLEOMORPHIC LIPOSARCOMA	NAME: ANGIOMYOLIPOMA	NAME: ANGIOMYOLIPOSARCOMA IN SITU	NAME: ANGIOMYOLIPOSARCOMA	NAME: ANGIOLIPOMA, NOS
NAME: CHONDROID LIPOMA	NAME: MYELOLIPOMA	NAME: HIBERNOMA	NAME: LIPOBLASTOMATOSIS	NAME: NA	NAME: LEIOMYOMA, NOS	NAME: LEIOMYOMATOSIS, NOS	NAME: LEIOMYOSARCOMA IN SITU
NAME: LEIOMYOSARCOMA, NOS	NAME: EPITHELIOID LEIOMYOMA	NAME: EPITHELIOID LEIOMYOSARCOMA IN SITU	NAME: EPITHELIOID LEIOMYOSARCOMA	NAME: CELLULAR LEIOMYOMA	NAME: BIZARRE LEIOMYOMA	NAME: ANGIOMYOMA	NAME: ANGIOMYOSARCOMA IN SITU
NAME: ANGIOMYOSARCOMA	NAME: MYOMA	NAME: MYOSARCOMA IN SITU	NAME: MYOSARCOMA	NAME: MYXOID LEIOMYOSARCOMA IN SITU	NAME: MYXOID LEIOMYOSARCOMA	NAME: SMOOTH MUSCLE TUMOR OF UNCERTAIN MALIG POTENT	NAME: METASTASIZING LEIOMYOMA
NAME: RHABDOMYOMA, NOS	NAME: RHABDOMYOSARCOMA IN SITU	NAME: RHABDOMYOSARCOMA, NOS	NAME: PLEOMORPHIC RHABDOMYOSARCOMA IN SITU, ADULT	NAME: PLEOMORPHIC RHABDOMYOSARCOMA, ADULT TYPE	NAME: MIXED TYPE RHABDOMYOSARCOMA IN SITU	NAME: MIXED TYPE RHABDOMYOSARCOMA	NAME: FETAL RHABDOMYOMA
NAME: ADULT RHABDOMYOMA	NAME: GENITAL RHABDOMYOMA	NAME: EMBRYONAL RHABDOMYOSARCOMA IN SITU	NAME: EMBRYONAL RHABDOMYOSARCOMA, NOS	NAME: SPINDLE CELL RHABDOMYOSARCOMA IN SITU	NAME: SPINDLE CELL RHABDOMYOSARCOMA	NAME: ALVEOLAR RHABDOMYOSARCOMA IN SITU	NAME: ALVEOLAR RHABDOMYOSARCOMA
NAME: RHABDOMYOSARCOMA W GANGLIONIC DIFF IN SITU	NAME: RHABDOMYOSARCOMA W GANGLIONIC DIFFERENTIATION	NAME: ENDOMETRIAL STROMAL NODULE	NAME: ENDOMETRIAL STROMAL SARCOMA IN SITU	NAME: ENDOMETRIAL STROMAL SARCOMA, NOS	NAME: ENDOMETRIAL STROMAL SARCOMA IN SITU, LOW GRD	NAME: ENDOMETRIAL STROMAL SARCOMA, LOW GRADE	NAME: ADENOMYOMA
NAME: ADENOSARCOMA IN SITU	NAME: ADENOSARCOMA	NAME: CARCINOFIBROMA IN SITU	NAME: CARCINOFIBROMA	NAME: STROMAL TUMOR, BENIGN	NAME: STROMAL TUMOR, NOS	NAME: STROMAL SARCOMA IN SITU	NAME: STROMAL SARCOMA, NOS
NAME: GASTROINTESTINAL STROMAL TUMOR, BENIGN	NAME: GASTROINTESTINAL STROMAL TUMOR, NOS	NAME: GASTROINTESTINAL STROMAL SARCOMA IN SITU	NAME: GASTROINTESTINAL AUTONOMIC NERVE TUMOR	NAME: PLEOMORPHIC ADENOMA	NAME: MIXED TUMOR, IN SITU	NAME: MIXED TUMOR, MALIGNANT, NOS	NAME: CARCINOMA IN PLEOMORPHIC ADENOMA IN SITU
NAME: CARCINOMA IN PLEOMORPHIC ADENOMA	NAME: MULLERIAN MIXED TUMOR IN SITU	NAME: MULLERIAN MIXED TUMOR	NAME: MESODERMAL MIXED TUMOR IN SITU	NAME: MESODERMAL MIXED TUMOR	NAME: BENIGN CYSTIC NEPHROMA	NAME: CYSTIC PARTIALLY DIFF NEPHROBLASTOMA	NAME: CYSTIC NEPHROMA IN SITU
NAME: MALIGNANT CYSTIC NEPHROMA	NAME: MESOBLASTIC NEPHROMA	NAME: NEPHROBLASTOMA IN SITU	NAME: NEPHROBLASTOMA, NOS	NAME: RHABDOID TUMOR IN SITU	NAME: MALIGNANT RHABDOID TUMOR	NAME: CLEAR CELL SARCOMA OF KIDNEY IN SITU	NAME: CLEAR CELL SARCOMA OF KIDNEY
NAME: NEPHROGENIC ADENOFIBROMA	NAME: RENOMEDULLARY INTERSTITIAL CELL TUMOR	NAME: OSSIFYING RENAL TUMOR	NAME: HEPATOBLASTOMA IN SITU	NAME: HEPATOBLASTOMA	NAME: PANCREATOBLASTOMA IN SITU	NAME: PANCREATOBLASTOMA	NAME: PULMONARY BLASTOMA IN SITU
NAME: PULMONARY BLASTOMA	NAME: PLEUROPULMONARY BLASTOMA IN SITU	NAME: PLEUROPULMONARY BLASTOMA	NAME: SIALOBLASTOMA	NAME: CALCIFYING NESTED EPITHELIAL STROMAL TUMOR (C22.0)	NAME: GASTROBLASTOMA	NAME: CARCINOSARCOMA IN SITU	NAME: CARCINOSARCOMA, NOS
NAME: CARCINOSARCOMA IN SITU, EMBRYONAL	NAME: CARCINOSARCOMA, EMBRYONAL	NAME: MYOEPITHELIOMA	NAME: MYOEPITHELIOMA IN SITU	NAME: MALIGNANT MYOEPITHELIOMA	NAME: ADENOMYOEPITHELIOMA	NAME: ADENOMYOEPITHELIOMA WITH CARCINOMA (C50._)	NAME: MESENCHYMOMA, BENIGN
NAME: MESENCHYMOMA, NOS	NAME: MESENCHYMOMA IN SITU	NAME: MESENCHYMOMA, MALIGNANT	NAME: EMBRYONAL SARCOMA IN SITU	NAME: EMBRYONAL SARCOMA	NAME: PULMONARY HAMARTOMA	NAME: BRENNER TUMOR, NOS	NAME: BRENNER TUMOR, BORDERLINE MALIGNANCY
NAME: BRENNER TUMOR IN SITU	NAME: BRENNER TUMOR, MALIGNANT	NAME: FIBROADENOMA, NOS	NAME: INTRACANALICULAR FIBROADENOMA	NAME: PERICANALICULAR FIBROADENOMA	NAME: ADENOFIBROMA, NOS	NAME: ADENOFIBROMA IN SITU	NAME: ADENOFIBROMA, MALIGNANT
For the entire list of entries see: Here

Customize PDF page

Package: Oncology

Global: ^ONCO(169.3

Information

Description

Accessed By FileMan Db Calls, Total: 3

Pointed To By FileMan Files, Total: 2

Pointer To FileMan Files, Total: 3

Fields, Total: 14

Found Entries, Total: 1642